Back to Search
Start Over
Chitosan-coated poly (Ɛ-caprolactone) nanoparticles as acaricide carriers.
- Source :
-
Ticks and tick-borne diseases [Ticks Tick Borne Dis] 2022 Jan; Vol. 13 (1), pp. 101849. Date of Electronic Publication: 2021 Oct 10. - Publication Year :
- 2022
-
Abstract
- Among many species of ticks that affect beef and dairy cattle, Rhipicephalus (Boophilus) microplus is the most common. It is responsible for heavy losses in milk and meat production. In this work we introduce nanostructures such as chitosan-poly-Ɛ-caprolactone (CS&#95;PCL) nanoparticles to encapsulate amitraz (CS&#95;PCLnp&#95;Amitraz) and fluazuron (CS&#95;PCLnp&#95;Fluazuron) to treat tick infestations more effectively. The CS&#95;PCLnp&#95;Amitraz system has a final amitraz concentration of 1.0 mg/mL with a particle size of 275 ± 30 nm, surface charge of +43 ± 7 mV and entrapment efficiency of 77 ± 1%. The CS&#95;PCLnp&#95;Fluazuron system has a drug concentration of 0.5 mg/mL with a particle size of 295 ± 35 nm, surface charge of +45 ± 10 mV and entrapment efficiency of 89 ± 1%. Both systems reduced cytotoxicity on Balb/c 3T3 culture cells and were also active against R. microplus. Both molecules - amitraz and fluazuron - formed molecularly dispersed active compounds inside the core of the PCL polymer matrix. The PCL surface was composed of a chitosan layer, which influenced the stability of the steric nanoparticles at pH greater than 7. Both systems were stable at a saline concentration of 1.25 mol/L and at temperatures below 50 °C. Experiments conducted in vivo with CS&#95;PCLnp&#95;Amitraz, at doses of active ingredient equivalent to those of commercial products, showed decreased tick infestation for 21 days, as well as higher acaricide effect than observed for commercial products, which recommend a reapplication in 14 days. The acaricide effect was even stronger when CS&#95;PCLnp&#95;Amitraz (same dose as for commercial products) and CS&#95;PCLnp&#95;Fluazuron (half of the amount for commercial products) were administered together.<br /> (Copyright © 2021 Elsevier GmbH. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1877-9603
- Volume :
- 13
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Ticks and tick-borne diseases
- Publication Type :
- Academic Journal
- Accession number :
- 34656044
- Full Text :
- https://doi.org/10.1016/j.ttbdis.2021.101849